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Complex Polymorphisms in an z330 kDa Protein
Are Linked to Chloroquine-Resistant
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²Institute of Pathology proposals that an overexpressed or mutatedP glycopro-
tein homolog was responsible for chloroquine resis-Case Western Reserve University
Cleveland, Ohio 44106 tance in P. falciparum (Martin et al., 1987). Two mdr-
like genes, pfmdr1 and pfmdr2, were identified in P.
falciparum (Foote et al., 1989; Wilson et al., 1989), but
these genes were not linked to chloroquine resistanceSummary
in a geneticcross (Wellems et al., 1990), and field studies
subsequently showed numerous exceptions to a pro-Chloroquine resistance in a P. falciparum cross maps
posed association between pfmdr1 or pfmdr2mutationsas a Mendelian trait to a 36 kb segment of chromo-
and chloroquine response (Borst and Ouellette, 1995;some 7. This segment harbors cg2, a gene encoding
von Seidlein et al., 1997). Chloroquine resistance of P.a unique z330 kDa protein with complex polymor-
falciparum parasites also contrasts with multiple drugphisms. A specific set of polymorphisms in 20 chlo-
resistance of tumor cells, in that it is constitutive androquine-resistant parasites from Asia and Africa, in
cannot be readily induced, suggesting a fundamentallycontrast with numerous differences in 21 sensitive
different resistance mechanism.parasites, suggests selection ofa cg2 allele originating
The production of a cross between a CQS clone fromin Indochina over 40 years ago. One chloroquine-sen-
Honduras (HB3) and a CQR clone from Indochina (Dd2)sitive clone exhibited this allele, suggesting another
provided a genetic approach to study the resistanceresistance component. South American parasites have
mechanism. A locus governing chloroquine responsecg2 polymorphisms consistent with a separate origin
was mapped to a 400 kb segment of chromosome 7of resistance. CG2 protein is found at the parasite
(Wellems et al., 1991), a segment expected to containperiphery, a site of chloroquine transport, and in asso-
80±100 genes at the average density of 5,000±7,000ciation with hemozoin of the digestive vacuole, where
genes in the 25,000±30,000 kb P. falciparum genome.chloroquine inhibits heme polymerization.
Such a large number of genes emphasized the need to
localize the determinant to a smaller segment of theIntroduction
chromosome. Here we report mapping of the CQR locus
to a 36 kb segment and identification of a candidateChloroquine, once a first-line drug in the abandoned
gene necessary to the resistance mechanism.campaign for global eradication of malaria, now fails
frequently against Plasmodium falciparum, the cause
of the most deadly human malaria (White, 1992). New Results
antimalarials that can take the place of chloroquine are a
need that underscores the importance of understanding Construction of a Microsatellite Map across
the action of this drug and the mechanism by which the Chromosome Segment Harboring the
chloroquine-resistant (CQR) P. falciparum parasites Chloroquine Resistance Determinant
counter its effects. Simple sequence repeats (SSRs or microsatellites) in the
Since the first reports of chloroquine resistance about 400 kb segment harboring the chloroquine resistance
40 years ago from two foci that appeared separately determinant were identified by sequencing plasmid in-
in South America and Southeast Asia, the molecular serts from libraries of Dd2 chromosome 7 restriction
mechanism of resistance has remained unknown. Chlo- fragments. From these SSRs, 24 markers were isolated
roquine accumulates to high levels in the acid environ- that distinguished polymorphisms between the CQS and
ment of parasite food vacuoles (Yayon et al., 1984, 1985; CQR parents of the HB3 3 Dd2 genetic cross. These
Sullivan et al., 1996), where it interferes with the seques- markers were assigned to restriction fragments, and a
tration of toxic heme produced by digestion of hemoglo- map of the 400 kb chromosome segment was con-
bin from the host red blood cells (Fitch, 1983; Slater and structed (Figure 1).
Cerami, 1992; Egan et al., 1994; Dorn et al., 1995). CQR
malaria parasites are thought to counter the effect of Localization of the Resistance Determinant
chloroquine by reducing its accumulation relative to that Previous studies showed that the P. falciparum genetic
in chloroquine-sensitive (CQS) parasites (Fitch, 1969, map unit distance is approximately 15±30 kb/cM (Walker-
1970). Leading theories propose altered transport mech- Jonah et al., 1992), suggesting that identification of addi-
anisms that affect drug uptake or efflux and thereby tional crossover events in HB3 3 Dd2 progeny would
decrease chloroquine levels within the food vacuoles localize the chloroquine resistance determinant to a
(Yayon et al., 1984; Krogstad et al., 1985, 1987; Verdier smaller region of the 400 kb segment. We therefore cloned
and examined 1,120 progeny from original samples of
infected chimpanzee blood. Microsatellite marker assays³To whom correspondence should be addressed.
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and 1H6 markers (Figure 1). These markers define a 36
kb segment of chromosome 7.
DNA Sequencing of the 36 kb Segment and
Identification of Transcribed Genes
A continuous 47,558 bp DNA sequence was assembled
using sequences from a Dd2 chromosome 7 subseg-
ment library and bridging PCR products where neces-
sary (Figure 2). Search of the 36 kb portion bounded
by the C408 and C188 crossovers identified the open
reading frames (ORFs) of eight potential genes having
an initiating methionine codon followed by at least 100
additional codons (cg1, cg2, cg3, cg4, cg6, cg7, cg8,
cg9). Comparison of the predicted sequences of these
ORFs against protein databases revealed homology of
the cg4 ORF to a heat-shock protein (hsp110 family), of
the cg3 ORF to Saccharomyces cerevisiae SCO1, and
of the cg6 ORF to an S. cerevisiae thioredoxin-like se-
quence. No other significant homologies were detected
in the remaining four sequences. A computer program
designed to predict P. falciparum genes (Saul and Batt-
istutta, 1988) showed typical codon usage and AT-rich
flanking sequences for all ORFs except cg1, which lacks
a typical AT-rich 59 flanking region and also possesses
a region of highly atypical codon usage within its reading
frame (resequencing of PCR products from this region
discounted the possibility of a frame shift).
Transcription from the eight potential genes was in-
vestigated by RT-PCR analysis, RNA blot hybridizations,
and screening of a Dd2 cDNA library (Creedon et al.,
1994) free of genomic DNAcontamination. These experi-
ments demonstrated transcription in erythrocyte stage
parasites of all genes except cg6. A 4 kb mRNA tran-
Figure 1. Map of the Chromosome Region Carrying the Determinant script was detected by probes from the cg9 and cg1
of the CQR Phenotype in the HB3 3 Dd2 Cross ORFs. An z10 kb mRNA band was detected by probes
Relative positions of the microsatellite markers are shown along the from the cg2 ORF. Transcription from all genes, deter-
chromosome line (arrows). Microsatellite inheritance patterns and
mined by quantitative PCR experiments, was found tochloroquine responses (S, sensitive; R, resistant) are listed for prog-
besimilar in theHB3 and Dd2 parasites (data not shown).eny Ch3±61, C408, C188, D43, and Ch3±116; polymorphisms that
We also screened the Dd2 cDNA library with amplifieddetect chromosome crossovers are shaded (H, HB3 genotype; D,
Dd2 genotype). The 36 kb segment containing the chloroquine resis- DNA fragments from the region between cg3 and cg9
tance determinant is bounded by the crossover sites between mark- to check for small transcribed genes not identified by
ers 7A11 and 2H4 of the C408 clone and between markers 3E7 and the sequence analysis. No cDNA clones were detected
1H6 of the C188 clone. Restriction sites: C, ClaI; L, SalI; K, KpnI; M,
that derived from this region.BamHI; N, NcoI; V, PvuII. The gray bar indicates the approximate
size and position of a previously described Dd2 variant antigen var
cluster (Su et al., 1995). Gene Polymorphisms Linked
to Chloroquine Resistance
As no major rearrangement in chromosome structure or
identified five meiotic crossover events at different change in gene expression was found to account for
points in the 400 kb segment among these progeny. The the resistance of Dd2 relative to HB3 parasites, we ex-
positions of these crossovers in clones Ch3±116, D43, amined genes of the 36 kb segment for complex struc-
C188, C408, and Ch3±61 are indicated in Figure 1. tural changes consistent with the slow genesis and
Chloroquine responses of the D43 and C408 progeny spread of chloroquine resistance. Comparison of the
clones matched that of the CQR Dd2 parent, whereas different HB3 and Dd2 gene sequences showed a strik-
responses of the Ch3±116, C188, and Ch3±61 clones ing collection of polymorphisms in the encoded amino
matched that of the CQS HB3 parent. As for all other acids of the cg2 gene. Included in these polymorphisms
progeny previously isolated, no intermediate or nonpa- were variations in three repetitive sequences (k, g, v),
rental responses were observed that would implicate changes in the length of a central poly-Asn tract, and
an additive or synergistic combination of two or more 12 individual point mutations affecting individual codons
unlinked genes in resistance. Comparison of the re- outside the repetitive sequences (Figure 3a). The cg1
sponses against marker inheritance patterns showed ORF showed less complex polymorphisms between the
that the locus controlling drug response lies between HB3 and Dd2 parasites, with four individual codon differ-
ences and variation in repeats (a) near the middle of thethe C408 and C188 crossover sites bounded by the 7A11
A Candidate Gene for Chloroquine Resistance
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Figure 2. Arrangement of Cloned Inserts and Sequencing Strategy for the Chromosome Segment Harboring the Chloroquine Resistance
Determinant in P. falciparum Clone Dd2
The shaded region indicates the 36 kb region containing the chloroquine resistance determinant. Assembled fragments (V to b), meiotic
breakpoints (vertical arrows), and restriction sites (vertical lines) are indicated above the chromosome line. Size and direction of the open
reading frames, presence of detectable mRNA transcripts, and predicted molecular weights of the encoded proteins are indicated below the
chromosome line. Introns in the hsp86 and cg7 genes were confirmed by RT-PCR. Restriction sites: N, NcoI; L, SalI; V, PvuII; K, KpnI; M,
BamHI; C, ClaI. Distance marks along the chromosome line have been set to correspond to nucleotide positions of the DNA sequence. Plus
sign, transcript detected; minus sign, transcript not detected.
sequence (Figure 3b). Polymorphisms in other genes regions containing genetically heterogeneous P. falci-
parum populations. Accordingly, we determined thewere found to be comparatively limited or silent. The
cg3 ORF showed a single codon difference between the chloroquine responses of parasite lines from different
regions of Asia and Africa and surveyed their DNA poly-HB3 and Dd2 parasites. A silent nucleotide difference
was detected in each of the cg6 and cg8 ORFs, and morphisms. Chloroquine responses of these parasites
all showed one of two clearly distinguishable pheno-two silent nucleotide changes were detected in the cg7
ORF. The coding sequences of cg4 and cg9 in the HB3 types: either a verapamil-reversible chloroquine IC50 of
40±120 ng/ml or a verapamil-insensitive chloroquine IC50and Dd2 parasites were found to be identical.
Previous work has shown that CQR parasites from of 2±9 ng/ml (Table 1). This clear discrimination of CQR
and CQS forms by IC50 response in the presence ofSouth America and Southeast Asia have comparable
levels of chloroquine resistance and verapamil reversal, verapamil isconsistent with findings previously reported
for P. falciparum strains from Asia, Africa, and Southalthough historical data argue that CQR parasites on
the two continents arose independently (Payne, 1987). America (Krogstad et al., 1992).
PCR amplification and direct sequencing were usedWe therefore determined the cg2 and cg1 sequences
of a CQR parasite from South America. The cg2 allele to survey the collected parasites for polymorphisms in
the cg8, cg4, cg3, cg1, cg6, cg2, and cg7 sequences.of this parasite (7G8) exhibits a number of congruent
as well as distinguishing polymorphisms that are in We focused this survey on parasites from Asia and East,
South, and West Africa, as the parent Dd2 clone wasagreement with the spread of chloroquine resistance
from two independent foci (Figure 3a). Outside the re- from Indochina, and the cg2and cg1 sequence compari-
sons were in agreement with different foci of chloroquinepeat regions, the 7G8 and Dd2 alleles of cg2 differ from
the HB3 allele by identical changes in seven codons resistance in Southeast Asia and South America. Re-
sults showed a strong pattern of linkage disequilibriumand by the same poly-Asn stretch. Six additional codon
changes not found in the Dd2 sequence also distinguish for cg1 and cg2 in the CQR parasites (Table 1). Except
for a single region of the Jcl isolate encompassing thethe 7G8 from the HB3 allele. Within the repeat regions,
the g repeats of the 7G8 and Dd2 alleles differ from HB3 59 polymorphisms of cg2, all Asian and African CQR
parasites were found to have identical cg1 and cg2 al-by the same changes, whereas the 7G8 variations in the
k, w, and v repeats are unique from those in either HB3 leles, linking one or both sequences to the resistance
mechanism of all parasite lines. This linkage is high-or Dd2. By contrast, the polymorphisms in cg1 are rela-
tively simple and show coincidence in the Asian and lighted by the exceptions that are apparent in the cg8,
cg4, and cg7 polymorphisms flanking the cg1 and cg2South American alleles only in a subset of the a repeats
(Figure 3b). sequences (Jcl and KMWII parasites; Table 1).
In contrast to CQR parasites, CQS parasites taken
from the same geographic regions showed many differ-Chloroquine Resistance and Linkage Disequilibrium
of cg1 and cg2 Polymorphisms in Asian ent arrangements of polymorphisms in cg1 and cg2 (Ta-
ble 1). Some cg1 and cg2 alleles in the CQS parasitesand African Parasites
P. falciparum in mosquitoes has an obligate sexual also showed additional polymorphisms not already de-
tected between the HB3 and Dd2 parasites (data notphase that produces frequent genetic recombination
among malaria parasites in areas of high transmission shown).
A single CQS clone, Sudan 106/1, was found to con-(Bayoumi et al., 1993; Babiker et al., 1994). A rigorous
test of a true candidate gene is therefore its linkage to tain cg1 and cg2 polymorphisms of the CQR Dd2 para-
site. DNA sequence of more than 20 kb from this clone,the spread of chloroquine resistance across malarious
Cell
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Figure 3. Alignment of Amino Acid Sequences Predicted by the cg2 and cg1 Genes
Diagrams above each alignment show the relative positions of the point amino acid differences (asterisks) and repeat regions in the deduced
amino acid sequences from cg2 (a) and cg1 (b). Alignments include the sequences from three clones that have different geographical origins
and drug responses: HB3 (Honduras, CQS), Dd2 (Indochina, CQR), and 7G8 (Brazil, CQR). Codon differences between the HB3 and Dd2
clones are numbered as in Table 1; other codon differences in the 7G8 sequence are shown in the alignments but not numbered or indicated
by asterisks. Boxed residues mark potential transmembrane helices in the cg2 ORF that were identified by different search algorithms (Devereux
et al., 1984; Engelman et al., 1986; Rost et al., 1996).
A Candidate Gene for Chloroquine Resistance
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Table 1. Drug Responses and Gene Polymorphisms of CQR and CQS Parasites from Distant Geographical Regions: Linkages within the 36
kb Segment of Chromosome 7
Chloroquine responses (ng/ml) were determined by microscopic and [3H]hypoxanthine uptake assays (IC50, Cq). The response levels were
reduced by the presence of 0.6 mM verapamil only for CQR parasites (IC50, Cq1V). Although Bayoumi et al. (1993) listed a chloroquine IC50
for the 106/1 clone that was 60% reversible by verapamil and relatively high for a CQS parasite, our assays with 106/1 samples showed no
significant difference from the HB3 and 105/7 clones in chloroquine response. DNA polymorphisms are listed from left to right according to
the gene order shown in Figure 2. For the cg8, cg6, and cg7 open reading frames, silent nucleotide differences of the Dd2 or HB3 genotype
are designated by d or h, respectively; a microsatellite polymorphism in the 59 flanking region of the cg4 gene is indicated by size corresponding
to HB3 (h), Dd2 (d), or other variant (v). Polymorphisms in the a, k, g, and v repeat regions of cg1 and cg2 are listed according to their unit
number of repeats. Numbers in the poly-Asn column designate the length of the asparagine stretch encoded by cg2. Other point differences
in the reading frames of cg3, cg1, and cg2 are indicated by the predicted amino acids. Some codon differences at additional positions in
CQS lines, but not found to differ between HB3 and Dd2, are not listed in the table. Polymorphisms of the Dd2 type are shown in bold type;
a dash indicates not determined. Parasites were obtained from geographically diverse stocks maintained at the National Institutes of Health
(Dolan et al., 1993) or kindly provided by investigators listed in the Acknowledgments (Sixsmith et al., 1984; Krogstad et al., 1987; Freese et
al., 1991; Bayoumi et al., 1993; Loureiro et al., 1996). Available stocks of the ItG2F6 and FCB parasites lines have been previously shown to
have gene sequence polymorphisms, pfmdr1 amplicons, and DNA fingerprints characteristic of an Asian origin (Robson et al., 1990; Triglia
et al., 1991; Dolan et al., 1993).
including the reading frames and flanking regions of kb away from the chloroquine resistance determinant
on chromosome 7; Peterson et al., 1995) have beencg9, cg1, cg6, cg2, cg7, and cg4, did not identify any
nucleotide that differed from the Dd2 sequence. Similar reported for some of these parasite lines (Liang and
Sim, 1997) and also have a distribution independent ofcg1 and cg2 transcript levels were found for the 106/1
and Dd2 parasites (data not shown). chloroquine response.
We also used microsatellites from the mapping studyGenetic polymorphisms outside the 36 kb segment
were surveyed to confirm our assumptions underlying (Figure 1) to examine polymorphisms in six CQR para-
sites and three CQS parasites, including the 106/1 para-the linkage disequilibrium analysis. Table 2 lists poly-
morphisms in the collected parasite lines of the Pgh1- site with the sequence of the Dd2-resistant form. Within
the segment harboring cg1 and cg2, polymorphisms ofendcoding gene (pfmdr1) in chromosome 5 and of the
dihydrofolate reductase±thymidylate synthase (dhfr/ts) the Dd2 type were found in 106/1 and all six CQR para-
sites, while those of the two other CQS parasites (105/7,gene in chromosome 4. As expected, codon changes
in these genes are not linked to chloroquine response. HB3) were distinct (Table 3). Outside this segment, the
microsatellites of the CQR parasites showed variation:Polymorphisms in the eba175 gene (located 500±1,000
Cell
598
Table 3. Microsatellite Markers in Neighborhood of the Chromo-Table 2. Amino Acid Polymorphisms Encoded by the dhfr/ts and
pfmdr1 Genes in CQR and CQS P. falciparum Lines some 7 Segment Carrying the Chloroquine Resistance Determinant
Shaded cells identify the microsatellite markers within the 36 kb
segment between the C408 and C188 crossovers. Identification of
the Dd2 (D), HB3 (H), or other microsatellite types (K, V, 2, 5) is by
size polymorphism; dash indicates not determined. Brackets mark
CQR and CQS lines listed in Table 1.
molecular weight standards were not available for a
protein of this size, the position extrapolated from avail-
able standards and from the positions of PfEMP1 and
PfEMP2/MESA proteins (courtesy of D. Baruch) indi-
cated a Mr of z330,000, consistent with the size pre-
dicted from the cg2 sequence.
Because different cross-reactive bands of smaller size
were also detected by these polyclonal antisera, we
generated monoclonal antibodies from mice immunized
with peptide CG2/B. Four resulting monoclonal antibod-
ies showed recognition of a single Mr z330,000 band
on immunoblots. In 4% polyacrylamide gels run for long
Amino acid polymorphisms in the dhfr/ts and pfmdr1 genes are periods to improve separation of the high molecular
those reported by Peterson et al. (1990) and Foote et al. (1990a, weight proteins, the band from HB3 parasites showed
1990b). Brackets mark CQR and CQS lines listed in Table 1; a dash
reduced mobility relative to the band from Dd2 para-indicates not determined.
sites, in agreement with the larger size predicted by the
v repeats (Figure 4b). These data indicate that the large
Mr band detected by the three different peptide antisera
below the 2E10 marker on the chromosome map (Fig- and the monoclonal antibodies is indeed that of the
ure 1; Table 3), microsatellites of the KMWII, FCB, and expressed gene product, CG2.
102/1 parasites were different from those of Dd2, and Immunofluorescence patterns from fixed erythrocyte
above the 7A11 marker in theopposite flanking segment, stage parasites were similar with all three polyclonal
distinct markers were evident in the V1/S, 102/1, and antisera (aCG2/B, aCG2/D, aCG2/E) and with two mono-
124/1 parasites. Of particular note is the 106/1 marker clonal antibodies chosen for further analysis (B11B5,
profile, which shows no difference from the profile of B4D12). CG2 was first clearly detected from late ring
the FCB parasite of Asian provenance (Table 1 legend). and early trophozoite stage parasites. Diffuse patterns
of fluorescence were detected from the parasites within
the erythrocytes, along with focal signals of strongerImmunolocalization of the CG2 Protein
in Erythrocyte Stage Parasites intensity suggesting vesicular distributions of protein
(data not shown). In mature schizonts, these vesicularTo probe for protein products from the cg1 and cg2
ORFs, we generated mouse antisera against KLH-cou- patterns were often pronounced, with concentrations of
signal in some cases abutting or overlapping pigmentpled peptides from different regions of the predicted
amino acid sequences. The antisera were confirmed by of the parasite food vacuole.
Subcellular localization of the CG2 was investigatedenzyme-linked immunosorbent assay (ELISA) to contain
antibodies against the appropriate unconjugated pep- by immunoelectron microscopy. In sections of tropho-
zoite- and early schizont±infected erythrocytes, goldtide. Antisera against the a repeat region and two other
regions of the cg1 sequence showed only nonspecific particles indicating the presence of CG2 were found at
the periphery of the parasite where the plasma mem-staining of both uninfected and infected red cells in
indirect immunofluorescence assays (IFA) (data not brane (pm) and the surrounding parasitophorous vacuo-
lar membrane (pvm) sandwich the parasitophorous vac-shown).
In contrast to these cg1 results, expression of cg2 uolar space (Figure 5a). The probed sections also
showed gold particle clusters indicating concentrationswas readily detected with antisera against three different
peptides predicted from the ORF. Immunoblots probed of CG2 in vesicles or vacuole-like structures of the para-
site cytoplasm (Figure 5b). Parasites in later stages ofwith these antisera (aCG2/B, aCG2/D, aCG2/E) all
showed a high molecular weight protein band from both development showed clusters of gold particles coloca-
lized with hemozoin crystals (Figure 5c). In mature foodCQR and CQS parasites (Figure 4a). Although precise
A Candidate Gene for Chloroquine Resistance
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Figure 4. Detection of the CG2 Protein by Immunoblotting
(a) Proteins from Dd2 erythrocyte stage parasites were separated,
blotted to nitrocellulose, andprobed with different antisera (aCG2/B,
aCG2/D, aCG2/E) or monoclonal antibodies (B11B5, B4D12, B12C1,
B13C5). Position of the Mr z330,000 CG2 band is indicated by the
arrow. Sera from mice prior to immunization (prebleed) and from
culture medium without antibody (medium) do not detect the band.
(b) Relative positions of CG2 from the Dd2 and HB3 parasites.
vacuoles, however, the gold particles often werepresent
Figure 5. Localization of the CG2 Protein by Immunoelectron Mi-
in a scattered distribution with fewer numbers of parti- croscopy
cles in the individual clusters (Figure 5d). Imaged sections of parasitized erythrocytes after reaction with
monoclonal antibody B4D12 and subsequent detection with gold-
labeled anti-mouse IgG. (a) Gold particles localize CG2 at the periph-Discussion
ery of a trophozoite where its plasma membrane (pm) meets the
surrounding parasitophorous vacuolar space and parasitophorous
CQR P. falciparum parasites spread steadily from two vacuolar membrane. (b) CG2 within a vesicular structure (ve) is indi-
foci that originated 40 years ago in South America and cated by clustered gold particles. (c) Gold particles over electron
dense pigment show colocalization of CG2with hemozoin (hz). Para-Southeast Asia after the massive use of chloroquine for
sitophorous vacuolar membrane (pvm) is indicated by arrows. (d)nearly a decade. The African continent was spared for
Section of a food vacuole (FV) shows particles within the interiora time, until CQR parasites entered East Africa in the
space and near the margin. P, parasite; E, erythrocyte.
1970s and subsequently swept across the continent.
Today, CQR malaria is present in nearly all malarious
regions except certain areas of the Middle East, Central missing. In contrast, diverse combinations of cg2 poly-
morphisms are present in CQS parasites from the corre-America, and the Caribbean. This steady and inexorable
march of chloroquine resistance from two foci is in con- sponding geographic regions, and polymorphisms in
other genes such as dhfr/ts, pfmdr1, and eba175 showtrast to the expansion of pyrimethamine-resistant P. fal-
ciparum strains, which contain simple point mutations in mixed distributions in both CQR and CQS parasites.
Taken together, these results provide strong evidencedihydrofolate reductase±thymidylate synthase that have
been selected many times (Peterson et al., 1988). The that chloroquine resistance in Indochina arose with a
particular set of mutations in the cg2 allele and subse-rare events of chloroquine resistance therefore suggest
that the genesis of CQR P. falciparum was complex, quently spread across Asia and Africa.
CQR parasites from South America show a cg2 allelerequiring a special combination of multiple mutations.
In the HB3 3 Dd2 cross, chloroquine resistance maps different from the CQR and CQS isolates of Southeast
Asia and Africa. Preliminary data indicate that a cg2as a Mendelian trait to a 36 kb segment of chromosome
7 in the Dd2 P. falciparum clone from Southeast Asia. allele (7G8 form; Figure 3) dominates across large re-
gions of the Brazilian Amazon where CQR malaria pre-This chromosome segment harbors a gene, cg2, that
encodes a unique z330 kDa protein with complex poly- vails today (unpublished data). While additional studies
will be required to establish firmly the role of cg2 inmorphisms expected of the chloroquine resistance ge-
notype. Relative to the CQS parent HB3, these polymor- the chloroquine resistance of South American parasites,
these findings are evidence that CQR parasites in thephisms include 12 individual codon changes, a length
variation in a central poly-Asn tract, and modifications Western Hemisphere had an origin separate from the
CQR strains of Southeast Asia and Africa.in the different sets of repeats. Our survey of parasites
from distant regions of Southeast Asia and Africa shows Constitutive expression of the cg2 gene in both CQR
and CQS parasites highlights the importance of struc-that this complete set of Dd2 polymorphisms is uni-
formly linked to chloroquine resistance in all but one tural polymorphisms in the chloroquine resistance
mechanism. In contrast to CQR parasites, CQS para-CQR parasite (Jcl), for which only the first three point
codon changes and a nearby repeat polymorphism are sites from Asia and Africa have a variety of different cg2
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alleles. Most of these alleles contain some but not all the peripheral membrane, where carrier-mediated up-
take of chloroquine is thought to occur (Sanchez et al.,of the polymorphisms found in CQR parasites and may
have existed independently in geographically distant 1997). It is also found in association with hemozoin of
the acid food vacuole, where chloroquine is thought toregions prior to the development of chloroquine resis-
tance. The particular combination of polymorphisms in exert its toxicity (Sullivan et al., 1996). The results further
suggest that vesicular trafficking of CG2 occurs betweenthe Dd2 cg2 gene may therefore have come together
by recombination to form an exact structure necessary these locations. CG2 is therefore exactly where a protein
involved in chloroquine resistance would be expected.for chloroquine resistance.
While the linkage and protein localization data provide While additional work will be required to define the pre-
cise function of CG2 in resistance, the spatial distribu-strong evidence for a central role of cg2 in chloroquine
resistance, additional determinants are likely to have tion already indicates that CG2 may affect transport
processes and play a critical role by mitigating theactiona complementary or permissive role in the resistance
mechanism. One finding that supports this view is the or concentration of chloroquine within the food vacuole.
In parasites already resistant to chloroquine, deampli-presence of the cg2 allele that predicts resistance in a
CQS isolate, the Sudan 106/1 clone. In this clone, the fication of the P. falciparum pfmdr1 gene paradoxically
increases chloroquine IC50 values, whereas pfmdr1 am-full cg2 gene sequence, its expression, and localization
of the CG2 product were found to be indistinguishable plification reduces chloroquine IC50 values, though not
to sensitive levels (Barnes et al., 1992; Cowman et al.,from those in the Dd2 parasite. Extensive DNA sequence
from the36 kb segment and polymorphisms of the flank- 1994). The pfmdr1 gene may thus have a secondary
effect on chloroquine concentrations in the vesicles ofing microsatellite markers in chromosome 7 were also
identical to those of the Dd2 parasite. These data indi- CQR parasites, a proposal that is supported by localiza-
tion of the pfmdr1 product to the parasite food vacuolecate that the chloroquine sensitivity of the 106/1 clone
cannot be ascribed to the chromosome segment mapped membrane (Cowman et al., 1991). By contrast, the ge-
netic linkage data and the cellular distribution of CG2in the HB3 3 Dd2 cross. Another locus appears to be
involved that resides elsewhere in the genome and is implicate a primary mechanism of resistance involving
processes at the parasite periphery as well as the vesi-essential to the mechanism of chloroquine resistance.
The sensitive nature of 106/1 may involve an unusual cles responsible for trafficking and hemoglobin diges-
tion. Indeed, an effect of CG2 on peripheral transportmutation or deletion at this other locus, as 106/1 is the
only CQS parasite in our collection to have the cg2 properties may explain the findings that a chloroquine
efflux phenotype (Krogstad et al., 1987; Wellems et al.,sequence of a CQR parasite. Another finding that re-
mains to be explained is the linkage disequilibrium of 1990) and chloroquine uptake kinetics sensitive to ami-
loride derivatives (Sanchez et al., 1997) are both linkedthe cg1 gene. The proximity of cg1 to cg2 (within 2 kb)
may account for this disequilibrium. Nevertheless, we to chloroquine response in the HB3 3 Dd2 cross.
The conservation of a single cg2 allele in CQR P.have not ruled out the possibility that cg1, perhaps in
concert with cg2, could be involved in resistance. Inves- falciparum parasites from widely separated regions of
Africa and Asia suggests that the resistance mechanismtigation of these issues should be feasible through a
genetic cross involving the 106/1 clone and targeted depends on the particular binding properties of the en-
coded structure. A stereospecific interaction may ex-modifications of the cg1 and cg2 sequences.
Various mechanisms for chloroquine resistance have plain why CQR parasites are susceptible to chloroquine
derivatives having length variations of the N-alkyl sidebeen proposed based on the findings that the concen-
tration of chloroquine is decreased in CQR parasites chain (De et al., 1996; Ridley et al., 1996) and to related
quinoline ring compounds having different substituentrelative to that in CQS parasites. Many of these propos-
als involve transporters that either affect chloroquine groups (Geary and Jensen, 1983; Hawley et al., 1996;
Kotecka et al., 1997). The identification of cg2 and itsflux directly or alter ion conductance that secondarily
affects chloroquine accumulation. These models incor- product will permit tests of this binding hypothesis
and functional dissection of the chloroquine resistanceporate in different ways the finding that chloroquine
resistance can be partially reversed by verapamil and mechanism.
other calcium channel blockers (Martin et al., 1987; Pe-
ters et al., 1989). In some models, reduced chloroquine Experimental Procedures
uptake has been attributed to the altered activity of
HB3 3 Dd2 Progeny Clones and DNA Preparationsion channels that determine Cl2 transport or Na1/H1
Progeny from the HB3 3 Dd2 cross were cloned directly from chim-exchange at the cytoplasmic membrane (Martiney et
panzee blood by limiting dilution into 96-well plates and detectedal., 1995; Sanchez et al., 1997), whereas others have
by color changes in the overlying medium after 3±7 weeks (Kirkman
proposed an altered proton pump at the food vacuole et al., 1996). Once color change was observed in a well, 100 ml of
membrane itself (Ginsburg and Stein, 1991; Bray et al., the sample was taken for PCR assay, and the remaining sample was
1992b). Alternative models involve energy-dependent expanded in culture and cryopreserved in Glycerolyte 57 (Baxter/
Fenwal Division, Deerfield, IL). Samples for DNA analysis were cen-export of chloroquine by a transporter of the ABC cas-
trifuged and resuspended in 150 ml of phosphate-buffered salinesette or mdr type (Krogstad et al., 1987; Martin et al.,
(PBS) containing 0.05% saponin. After centrifugation again at1987). Our searches of the cg2 ORF have not identified
3,000 3 g for 5 min and removal of the hemoglobin-containing
homology with an ion channel or transporter favoring supernatant, the parasites were washed once with 150 ml of PBS,
one or another of these different models. pelleted, resuspended in 100 ml H2O, and heated for 10 min at 1008C.
Immunoelectron microscopy of intraerythrocytic par- The samples were immediately tested or frozen at 2208C until further
use.asites shows that the CG2 protein is located near or at
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Identification of Simple Sequence Repeats (SSRs) anti-mouse IgG (Amersham International Plc., Amersham, UK) di-
luted 1:20 in PBS±Tween 20±BSA. The sections were washed withand Microsatellite Assays
Plasmid clones were selected from libraries constructed from seg- PBS±Tween 20±BSA, fixed with 2.5% glutaraldehyde in 0.1 M phos-
phate buffer (pH 7.4), rinsed with distilled water, and finally counter-ments of P. falciparum Dd2 chromosome 7 (Wellems et al., 1991).
Inserts with polymorphic SSRs were radiolabeled and mapped to stained with 2% uranyl acetate and 1% leadcitrate. Specificity of the
reaction was confirmed by control experiments with a nonrelevantrestriction fragments of genomic DNA. Sequences and amplification
conditions are listed in detail in supplemental Table 4, available on mouse MAb.
the Internet (http://www.cell.com/cgi/content/full/91/5/593/T4).
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